N-[(2S)-but-3-yn-2-yl]-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
Structure Info
- Chemspace ID
- CSSB02522298922 (In-Stock Building Blocks)
- IUPAC Name
- N-[(2S)-but-3-yn-2-yl]-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
- Mol formula
- C18H24BNO3
- Mol weight
- 313 Da
- Catalog Number(s)
- BBLS02522298922, BBV-325622805, EN300-55176192, bbls02522298922
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.95
- Heavy atoms count
- 23
- Rotatable bond count
- 3
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.5
- Polar surface area (Å)
- 48
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(2S)-but-3-yn-2-yl]-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (C18H24BNO3) - CSSB02522298922](/st/structure/200/4da22b88780cbb3a4ccabbb441eb843c/C%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DCC%253DC%2528C%2529C%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2523C.png "C18H24BNO3")
- Zoom the structure
- CSSB02522298922
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[(2R)-but-3-yn-2-yl]-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB02522299010](/st/structure/200/2e712fb91665e125955b84e8f78a7a87/C%255BC%2540%2540H%255D%2528NC%2528%253DO%2529C1%253DCC%253DC%2528C%2529C%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2523C.png)
![Chemical structure of N-[(2S)-but-3-yn-2-yl]-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB02522226334](/st/structure/200/5bb03435bb511bcbff32ae528b984537/C%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DCC%253DC%2528B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529C%2528C%2529%253DC1%2529C%2523C.png)
![Chemical structure of N-[(2R)-but-3-yn-2-yl]-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB02522226415](/st/structure/200/7fc70d26290d46af618de84a6ababed0/C%255BC%2540%2540H%255D%2528NC%2528%253DO%2529C1%253DCC%253DC%2528B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529C%2528C%2529%253DC1%2529C%2523C.png)
![Chemical structure of N-[(2S)-but-3-yn-2-yl]-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB02522297669](/st/structure/200/f48c47cfd424c55d3995c7e7d2719044/C%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DCC%2528%253DCC%253DC1C%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1%2529C%2523C.png)
